# Tailoring Varenicline to Individual Needs (TVIN Study)

> **NCT01206010** · PHASE3 · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 200 (actual)

## Conditions studied

- Tobacco Dependence
- Smoking Cessation

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo
- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT01206010
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-11
- **Final completion:** 2013-02
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2013-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206010, "Tailoring Varenicline to Individual Needs (TVIN Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01206010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*